HAE, ELGX, XRAY...BMO Capital Highlights This Week's MedTech Earnings

Halfway through earnings season and analysts at BMO Capital Markets have noticed the following themes regarding MedTech companies:

• Q2 has no clear theme of upward revisions, like what the market saw in Q1
• Companies with large market cap have beat revenue, and virtually all have beaten EPS estimates also

In a note to investors, BMO highlighted earnings this week in MedTech, noting that they are now focusing more on small-cap names.

Monday 8/1

• Haemonetics Corporation HAE - Reported pre-market (PM), Q1 EPS $0.25 vs $0.29 estimated, revenues of $209.96M vs $205.24M estimated
• Glaukos Corp GKOS - After hours (AH)
• Orthofix International NV OFIX - AH

Tuesday 8/2

• Mazor Robotics Ltd MZOR - PM
• Wright Medical Group WMGI - AH
• Endologix, Inc ELGX - AH
• DexCom, Inc DXCM - AH
• Intersect ENT Inc XENT - AH

Wednesday 8/3

• Insulet Corporation PODD - AH
• STAAR Surgical Company STAA - AH
• Cardiovascular Systems Inc CSII - AH
• K2M Group Holdings Inc KTWO - AH

Thursday 8/4

• Becton Dickinson and Co BDX - PM
• Hill-Rom Holdings, Inc HRC - PM
• Rewalk Robotics Ltd RWLK - PM
• DENTSPLY SIRONA Inc XRAY - PM
• AtriCure Inc ATRC - AH

BMO expects fundamental to be in the spotlight as the remainder of earnings season unfolds.